Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Neoplasm Metastasis 18 Prostatic Neoplasms 12 Lung Neoplasms 10 Carcinoma, Renal Cell 10 Carcinoma, Hepatocellular 10 Melanoma 9 Carcinoma, Non-Small-Cell Lung 9 Sarcoma 8 Liver Neoplasms 8 Kidney Neoplasms 8 Pain 6 Colorectal Neoplasms 6 Esophageal Neoplasms 4 Triple Negative Breast Neoplasms 3 Thyroid Neoplasms 3 Small Cell Lung Carcinoma 3 Osteosarcoma 3 Neoplasms 3 Keratosis, Actinic 3 Desmoid Tumors 3 Colonic Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Ductal, Breast 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2

Interventions

pembrolizumab 24 Nivolumab 23 aldesleukin 21 Cyclophosphamide 20 Ipilimumab 17 Interleukin-2 17 fludarabine 15 fludarabine phosphate 14 cemiplimab 12 Radiotherapy 7 Fluorouracil 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Dacarbazine 6 trametinib 5 binimetinib 5 Vemurafenib 5 Temozolomide 5 Surgical Procedures, Operative 5 Sirolimus 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 sonidegib 4 encorafenib 4 Photochemotherapy 4 Mohs Surgery 4 HhAntag691 4 Educational Status 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × Cryosurgery × Clear all

NCT05779423 2026-05-19

Cryoablation+Ipilimumab+Nivolumab in Melanoma

Massachusetts General Hospital

Phase 2 Recruiting

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡